Kinjo, T., Kitaguchi, Y., Droma, Y., Yasuo, M., Wada, Y., Ueno, F., . . . Hanaoka, M. (2020). The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. Sci Rep.
Chicago Style CitationKinjo, Takumi, Yoshiaki Kitaguchi, Yunden Droma, Masanori Yasuo, Yosuke Wada, Fumika Ueno, Masao Ota, and Masayuki Hanaoka. "The Gly82Ser Mutation in AGER Contributes to Pathogenesis of Pulmonary Fibrosis in Combined Pulmonary Fibrosis and Emphysema (CPFE) in Japanese Patients." Sci Rep 2020.
MLA CitationKinjo, Takumi, et al. "The Gly82Ser Mutation in AGER Contributes to Pathogenesis of Pulmonary Fibrosis in Combined Pulmonary Fibrosis and Emphysema (CPFE) in Japanese Patients." Sci Rep 2020.